NEUROINDX INC.
Medtech · Private
On-chip functional assay for screening microtubule-binding drug candidates
- Grants
- $3.3M
- 8 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Low-cost microdissection system for live brain cell collection (CTAS-Live) | $506,825 | |
| Federal grant | Department of Health and Human Services · Phase I · Noninvasive collection of cell and region specific miRNA from heterogeneous tissues. | $190,311 | |
| Federal grant | Department of Health and Human Services · Phase I · Noninvasive collection of cell and region specific miRNA from heterogeneous tissues. | $40,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Automated Platform for Fixed Tissue Microdissection | $265,643 | |
| Federal grant | Department of Health and Human Services · Phase II · Automated Platform for Fixed Tissue Microdissection | $747,594 | |
| Federal grant | Department of Health and Human Services · Phase II · Automated Platform for Fixed Tissue Microdissection | $718,448 | |
| Federal grant | Department of Health and Human Services · Phase I · High throughput single cell linear displacement adhesion assay | $350,000 | |
| Federal grant | Department of Health and Human Services · Phase I · On-Chip Assay for Identifying Candidate Microtubule Binding Drugs to Treat ADRDs | $514,862 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1834 | MIZAR IMAGING LLC | — | — |
| 1835 | ALLERGY AMULET, INC. | — | — |
| 1836 | GRADIENT MEDICAL, INC. | — | — |
| 1837 | NEUROINDX INC. | — | — |
| 1838 | NAMI DIAGNOSTICS LLC | — | — |
| 1839 | ENDOPROTECH, INC. | — | — |
| 1840 | SUBTLE MEDICAL, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.